Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
2016 | |||
Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir Journal:International Journal of Cancer | 2016 | ||
Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304) Journal:Journal of Thoracic Oncology | 2010 |